Skip to content

The Anemia Control Program: High or Low Iron Supplementation

Iron Deficiency Anemia and Infant Behavior: Preventive Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01166451
Enrollment
835
Registered
2010-07-21
Start date
1991-09-30
Completion date
2004-03-31
Last updated
2011-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Development, Iron Deficiency Anemia, Motor Development

Keywords

iron deficiency anemia, cognitive development, motor development

Brief summary

The purpose of this clinical trial was to determine if high-iron or low-iron formula, containing an average of 12.7 mg/L or 2.3 mg/L respectively, had differing effects on iron status in infancy and on development longitudinally.

Detailed description

For a detailed description of the clinical trial setting and procedures in infancy, please refer to the following: Walter T, Pino P, Pizarro F and Lozoff B. Prevention of iron-deficiency anemia: Comparison of high- and low-iron formulas in term healthy infants after six months of life. J Pedr 1998:132:635-40.

Interventions

DIETARY_SUPPLEMENTLow-iron formula

Infants randomly assigned at 6 months of age to receive low-iron formula (average 2.3 mg/L, range 1.6 - 2.4 mg/L) until 12 months of age. Low-iron formula distributed in powdered form. Project personnel visited infants' homes weekly to record measures of powdered formula used per day. Formula consumption was also verified by the number of cans given by the clinic nurse at each visit (regular pediatric visits and monthly clinic appointments until 12 months of age.)

DIETARY_SUPPLEMENTHigh-iron formula

Infants randomly assigned at 6 months of age to receive high-iron formula (average 12.7 mg/L) until 12 months of age. High-iron formula distributed in powdered form. Project personnel visited infants' homes weekly to record measures of powdered formula used per day. Formula consumption was also verified by the number of cans given by the clinic nurse at each visit (regular pediatric visits and monthly clinic appointments until 12 months of age.)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Months to 6 Months
Healthy volunteers
No

Inclusion criteria

* Birth weight \>= 3.0 kg * single birth * no major congenital anomalies * no major birth or neonatal complications * no emergency c-section * no jaundice requiring phototherapy * no hospitalization for more than 5 days * no chronic illness * no iron therapy * already started to received some bottle feedings by 6 months of age

Exclusion criteria

* residence outside identified neighborhoods * another infant \<12 months in household * infant in daycare * unstable, illiterate, or psychotic caregiver

Design outcomes

Primary

MeasureTime frame
Iron deficiency anemia12 and 18 months

Secondary

MeasureTime frame
Longitudinal child behavior and development10 years

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026